Get the Stockscreener App
9.18
0.88%
+0.08
Phathom Pharmaceuticals Inc Stock (PHAT) Forecast
The Phathom Pharmaceuticals Inc (PHAT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $22.24, representing a +142.24% increase from the current price of $9.18. The highest analyst price target is $29.61, and the lowest is $14.86.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PHAT Price Target
Average 28.89
(+214.70% Upside)
Is Phathom Pharmaceuticals Inc (PHAT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.31 | Neutral |
| STOCH(9,6) | 12.96 | Buy |
| STOCHRSI(14) | 9.74 | Buy |
| MACD(12,26) | -0.1922 | Sell |
| ADX(14) | 19.26 | Neutral |
| William %R | -87.54 | Buy |
| CCI(14) | -66.78 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.377
Sell
|
9.4292
Sell
|
| MA20 |
10.07
Sell
|
9.686
Sell
|
| MA50 |
9.7746
Sell
|
9.5149
Sell
|
| MA100 |
8.8385
Buy
|
9.3508
Sell
|
| MA200 |
10.14
Sell
|
9.5082
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, PHAT could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 10 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on PHAT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.31 indicates that PHAT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.96 indicates that PHAT is oversold. This indicates that PHAT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.74 indicates that PHAT is oversold. This suggests that PHAT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.26 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.78 indicates that PHAT is still oversold but not to an extreme extent.
Long-term PHAT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Phathom Pharmaceuticals Inc financial reports and earnings history, Phathom Pharmaceuticals Inc (PHAT) stock could reach $13.36 by 2030, $12.79 by 2040 and $46.34 by 2050. See the projected annual prices until 2050 of the Phathom Pharmaceuticals Inc stock below:
- Phathom Pharmaceuticals Inc (PHAT) is expected to reach an average price of $3.4828 in 2035, with a high prediction of $5.4209 and a low estimate of $0.05. This indicates an $-62.06% rise from the last recorded price of $9.18.
- Phathom Pharmaceuticals Inc (PHAT) stock is projected to chart a bullish course in 2040, with an average price target of $13.93, representing an $51.75% surge from its current level. The forecast ranges from a conservative $12.75 to a sky-high $12.79.
- Our analysts predict Phathom Pharmaceuticals Inc (PHAT) to jump 237.85% by 2045, soaring from $22.92 to an average price of $31.01, potentially reaching $22.98. While $22.92 is the low estimate, the potential upside is significant.
- Phathom Pharmaceuticals Inc (PHAT) stock is expected to climb by 2050, reaching an average of $44.99, a $390.07% jump from its current level. However, a wide range of estimates exists, with high and low targets of $46.34 and $45.42, respectively, highlighting the market's uncertainty.
Phathom Pharmaceuticals Inc Stock (PHAT) Year by Year Forecast
Phathom Pharmaceuticals Inc Stock (PHAT) Price Forecast for 2024
Our forecast for PHAT stock price in 2024 now indicates an average price target of $26.83 with a high forecast of $50.41 and a low forecast of $3.2529. The average prediction reflects an increase of +192.29% from the last recorded price of $9.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $16.53 | $14.86 | $29.61 | +80.03% |
| June, 2024 | $15.53 | $7.3673 | $16.15 | +69.15% |
| July, 2024 | $17.13 | $13.02 | $26.50 | +86.60% |
| August, 2024 | $28.07 | $15.85 | $33.61 | +205.79% |
| September, 2024 | $18.90 | $17.38 | $50.41 | +105.91% |
| October, 2024 | $17.22 | $14.25 | $19.57 | +87.62% |
| November, 2024 | $26.12 | $17.31 | $27.05 | +184.48% |
| December, 2024 | $24.46 | $19.01 | $26.68 | +166.41% |
Phathom Pharmaceuticals Inc Stock (PHAT) Price Forecast for 2025
Phathom Pharmaceuticals Inc Stock (PHAT) is expected to reach an average price of $28.39 in 2025, with a high prediction of $38.39 and a low estimate of $18.40. This indicates an +209.31% rise from the last recorded price of $9.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $26.05 | $20.16 | $27.78 | +183.75% |
| February, 2025 | $28.57 | $21.81 | $30.28 | +211.21% |
| March, 2025 | $32.29 | $23.68 | $33.79 | +251.75% |
| April, 2025 | $20.51 | $19.95 | $37.90 | +123.44% |
| May, 2025 | $25.86 | $19.73 | $27.96 | +181.74% |
| June, 2025 | $33.46 | $24.68 | $35.94 | +264.43% |
| July, 2025 | $25.29 | $22.91 | $38.39 | +175.45% |
| August, 2025 | $27.71 | $21.93 | $29.81 | +201.83% |
| September, 2025 | $23.44 | $19.35 | $28.83 | +155.33% |
| October, 2025 | $23.25 | $19.82 | $24.79 | +153.27% |
| November, 2025 | $22.33 | $21.83 | $24.00 | +143.27% |
| December, 2025 | $20.16 | $18.40 | $23.49 | +119.64% |
Phathom Pharmaceuticals Inc Stock (PHAT) Price Forecast for 2026
The predicted value for Phathom Pharmaceuticals Inc (PHAT) in 2026 is set at an average of $13.63. Estimates vary from a peak of $25.90 to a trough of $1.3544, indicating an +48.47% surge from the present price of $9.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $22.15 | $19.92 | $25.90 | +141.34% |
| February, 2026 | $21.05 | $19.90 | $24.94 | +129.26% |
| March, 2026 | $11.48 | $10.85 | $23.38 | +25.03% |
| April, 2026 | $7.2387 | $7.0887 | $12.53 | -21.15% |
| May, 2026 | $9.25 | $6.754 | $9.46 | +0.76% |
| June, 2026 | $6.0316 | $3.6613 | $9.8406 | -34.30% |
| July, 2026 | $7.7028 | $5.6825 | $9.7728 | -16.09% |
| August, 2026 | $3.1244 | $1.3544 | $9.2332 | -65.96% |
| September, 2026 | $5.2657 | $2.6901 | $6.2521 | -42.64% |
| October, 2026 | $1.857 | $1.777 | $5.6135 | -79.77% |
| November, 2026 | $2.2914 | $1.6305 | $1.9918 | -75.04% |
| December, 2026 | $0.8502 | $1.3702 | $2.5661 | -90.74% |
Phathom Pharmaceuticals Inc Stock (PHAT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Phathom Pharmaceuticals Inc (PHAT) is $3.607, with a high forecast of $7.213 and a low forecast of $0.00109. This indicates an -60.71% decrease from the last price of $9.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6311 | $0.00109 | $1.8005 | -93.13% |
| February, 2027 | $1.5724 | $0.00859 | $3.8424 | -82.87% |
| March, 2027 | $1.6139 | $0.0161 | $1.8439 | -82.42% |
| April, 2027 | $1.1352 | $0.5293 | $3.6346 | -87.63% |
| May, 2027 | $2.1868 | $0.6268 | $3.2059 | -76.18% |
| June, 2027 | $2.0881 | $0.7578 | $2.5471 | -77.25% |
| July, 2027 | $3.1393 | $1.3687 | $3.5393 | -65.80% |
| August, 2027 | $4.0509 | $0.0547 | $5.5206 | -55.87% |
| September, 2027 | $1.8222 | $0.1617 | $4.5016 | -80.15% |
| October, 2027 | $0.9565 | $0.4678 | $2.4525 | -89.58% |
| November, 2027 | $3.2251 | $0.00504 | $3.6251 | -64.87% |
| December, 2027 | $6.0463 | $2.5954 | $7.213 | -34.14% |
Phathom Pharmaceuticals Inc Stock (PHAT) Price Forecast for 2028
In 2028, Phathom Pharmaceuticals Inc (PHAT) is projected to reach an average price of $8.998, with a high projection of $17.40 and a low estimate of $0.5917. This indicates an -1.98% fall from the last price of $9.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.1079 | $4.227 | $6.6766 | -44.36% |
| February, 2028 | $7.2292 | $4.6682 | $8.7717 | -21.25% |
| March, 2028 | $7.9804 | $6.1598 | $8.8901 | -13.07% |
| April, 2028 | $7.8817 | $7.4908 | $10.39 | -14.14% |
| May, 2028 | $4.0633 | $3.7033 | $8.3374 | -55.74% |
| June, 2028 | $2.5146 | $2.0746 | $4.6239 | -72.61% |
| July, 2028 | $1.4562 | $0.8055 | $4.1852 | -84.14% |
| August, 2028 | $2.9374 | $0.9665 | $3.5374 | -68.00% |
| September, 2028 | $7.2987 | $2.3377 | $6.64 | -20.49% |
| October, 2028 | $6.4356 | $5.9075 | $4.2642 | -29.90% |
| November, 2028 | $0.787 | $1.128 | $17.40 | -91.43% |
| December, 2028 | $5.5195 | $0.5917 | $8.5795 | -39.87% |
Phathom Pharmaceuticals Inc Stock (PHAT) Price Forecast for 2029
The 2029 price forecast for Phathom Pharmaceuticals Inc Stock (PHAT) is $18.21 on average, with a high prediction of $36.28 and a low estimate of $0.132. This represents an +98.34% increase from the previous price of $9.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.4927 | $0.4908 | $14.76 | -29.27% |
| February, 2029 | $4.6548 | $0.132 | $13.03 | -49.29% |
| March, 2029 | $1.4978 | $0.3671 | $7.4678 | -83.68% |
| April, 2029 | $9.9709 | $1.4316 | $19.28 | +8.62% |
| May, 2029 | $21.18 | $6.5016 | $36.28 | +130.76% |
| June, 2029 | $3.646 | $2.486 | $19.50 | -60.28% |
| July, 2029 | $7.1392 | $0.3673 | $7.3592 | -22.23% |
| August, 2029 | $9.5517 | $6.4111 | $13.36 | +4.05% |
| September, 2029 | $7.9243 | $5.4637 | $11.35 | -13.68% |
| October, 2029 | $13.32 | $7.8662 | $14.46 | +45.07% |
| November, 2029 | $17.05 | $8.6537 | $17.79 | +85.73% |
| December, 2029 | $12.26 | $11.95 | $25.02 | +33.59% |
Phathom Pharmaceuticals Inc Stock (PHAT) Price Forecast for 2030
Phathom Pharmaceuticals Inc Stock (PHAT) is expected to reach an average price of $13.00 in 2030, with a high forecast of $25.99 and a low forecast of $0.0151. This signifies an +41.64% surge from the last price of $9.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $12.12 | $6.9751 | $13.36 | +31.98% |
| February, 2030 | $19.47 | $12.09 | $19.89 | +112.07% |
| March, 2030 | $20.40 | $15.29 | $25.99 | +122.23% |
| April, 2030 | $14.10 | $9.7339 | $21.18 | +53.64% |
| May, 2030 | $10.90 | $8.9365 | $16.76 | +18.70% |
| June, 2030 | $9.689 | $7.3978 | $15.12 | +5.54% |
| July, 2030 | $11.32 | $9.1037 | $12.99 | +23.34% |
| August, 2030 | $9.0847 | $7.4497 | $12.06 | -1.04% |
| September, 2030 | $12.98 | $7.0166 | $13.17 | +41.37% |
| October, 2030 | $9.5804 | $9.0404 | $14.64 | +4.36% |
| November, 2030 | $10.55 | $8.7911 | $12.39 | +14.96% |
| December, 2030 | $1.4838 | $0.0151 | $11.57 | -83.84% |
1.53%
3.38%
Cap:
|
Volume (24h):